新冠疫情：对皮质类固醇保持冷静态度。 - Suppr

Suppr

超能文献

COVID-19: Stay Cool toward Corticosteroids.

作者信息

Fujishima Seitaro

机构信息

Editor-in-Chief, The Keio Journal of Medicine.

Center for General Medicine Education, Keio University School of Medicine.

出版信息

Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.

DOI:10.2302/kjm.2020-0007-LE

PMID:32475851

Abstract

摘要

相似文献

COVID-19: Stay Cool toward Corticosteroids.

Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.

Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.

Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?

Mol Cell. 2020 Jul 2;79(1):9-10. doi: 10.1016/j.molcel.2020.06.024.

Understanding of COVID-19 based on current evidence.

J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.

COVID-19: Small-Molecule Clinical Trials Landscape.

Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.

Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.

Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.

Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.01009-2020. Print 2020 May.

COVID-19: The Need for Immunoprevention at Industrial Scale.

Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.

[Not Available].

Rev Med Suisse. 2020 Mar 11;16(685):510-511.

Pros and cons of corticosteroid therapy for COVID-19 patients.

Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.

引用本文的文献

The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19.

Front Mol Biosci. 2024 Jan 11;10:1326111. doi: 10.3389/fmolb.2023.1326111. eCollection 2023.

COVID-19 and corticosteroids: a narrative review.

Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13.

Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection.

Case Rep Ophthalmol Med. 2021 Oct 28;2021:9745701. doi: 10.1155/2021/9745701. eCollection 2021.

COVID-19, corticosteroids and public health: a reappraisal.

Public Health. 2021 Aug;197:48-55. doi: 10.1016/j.puhe.2021.05.028. Epub 2021 Jun 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19: Stay Cool toward Corticosteroids.

Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.

Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.

Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.

Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research?

Mol Cell. 2020 Jul 2;79(1):9-10. doi: 10.1016/j.molcel.2020.06.024.

Understanding of COVID-19 based on current evidence.

J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.

COVID-19: Small-Molecule Clinical Trials Landscape.

Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.

Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.

Am J Trop Med Hyg. 2020 Jun;102(6):1154-1155. doi: 10.4269/ajtmh.20-0262.

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.

Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.01009-2020. Print 2020 May.

COVID-19: The Need for Immunoprevention at Industrial Scale.

Am J Trop Med Hyg. 2020 Jun;102(6):1151. doi: 10.4269/ajtmh.20-0239.

[Not Available].

Rev Med Suisse. 2020 Mar 11;16(685):510-511.

Pros and cons of corticosteroid therapy for COVID-19 patients.

Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.

引用本文的文献

The analysis of low-dose glucocorticoid maintenance therapy in patients with primary nephrotic syndrome suffering from COVID-19.

Front Mol Biosci. 2024 Jan 11;10:1326111. doi: 10.3389/fmolb.2023.1326111. eCollection 2023.

COVID-19 and corticosteroids: a narrative review.

Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13.

Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection.

Case Rep Ophthalmol Med. 2021 Oct 28;2021:9745701. doi: 10.1155/2021/9745701. eCollection 2021.

COVID-19, corticosteroids and public health: a reappraisal.

Public Health. 2021 Aug;197:48-55. doi: 10.1016/j.puhe.2021.05.028. Epub 2021 Jun 7.